Tome ME - Search Results

1

Mitochondrial adaptations to oxidative stress confer resistance to apoptosis in lymphoma cells.

Wilkinson ST, Tome ME, Briehl MM. Wilkinson ST, et al. Among authors: tome me. Int J Mol Sci. 2012;13(8):10212-10228. doi: 10.3390/ijms130810212. Epub 2012 Aug 16. Int J Mol Sci. 2012. PMID: 22949856 Free PMC article.

2

Induction of oxidative stress and apoptosis in myeloma cells by the aziridine-containing agent imexon.

Dvorakova K, Payne CM, Tome ME, Briehl MM, McClure T, Dorr RT. Dvorakova K, et al. Among authors: tome me. Biochem Pharmacol. 2000 Sep 15;60(6):749-58. doi: 10.1016/s0006-2952(00)00380-4. Biochem Pharmacol. 2000. PMID: 10930529

3

Catalase-overexpressing thymocytes are resistant to glucocorticoid-induced apoptosis and exhibit increased net tumor growth.

Tome ME, Baker AF, Powis G, Payne CM, Briehl MM. Tome ME, et al. Cancer Res. 2001 Mar 15;61(6):2766-73. Cancer Res. 2001. PMID: 11289160

4

Induction of mitochondrial changes in myeloma cells by imexon.

Dvorakova K, Waltmire CN, Payne CM, Tome ME, Briehl MM, Dorr RT. Dvorakova K, et al. Among authors: tome me. Blood. 2001 Jun 1;97(11):3544-51. doi: 10.1182/blood.v97.11.3544. Blood. 2001. PMID: 11369649 Free article.

5

Thymocytes selected for resistance to hydrogen peroxide show altered antioxidant enzyme profiles and resistance to dexamethasone-induced apoptosis.

Tome ME, Briehl MM. Tome ME, et al. Cell Death Differ. 2001 Sep;8(9):953-61. doi: 10.1038/sj.cdd.4400904. Cell Death Differ. 2001. PMID: 11526450

6

Changes in phosphate metabolism in thymoma cells suggest mechanisms for resistance to dexamethasone-induced apoptosis. A 31P NMR spectroscopic study of cell extracts.

Lutz NW, Tome ME, Aiken NR, Briehl MM. Lutz NW, et al. Among authors: tome me. NMR Biomed. 2002 Aug;15(5):356-66. doi: 10.1002/nbm.790. NMR Biomed. 2002. PMID: 12203227

7

Imexon activates an intrinsic apoptosis pathway in RPMI8226 myeloma cells.

Dvorakova K, Payne CM, Landowski TH, Tome ME, Halperin DS, Dorr RT. Dvorakova K, et al. Among authors: tome me. Anticancer Drugs. 2002 Nov;13(10):1031-42. doi: 10.1097/00001813-200211000-00007. Anticancer Drugs. 2002. PMID: 12439337

8

Molecular and cellular characterization of imexon-resistant RPMI8226/I myeloma cells.

Dvorakova K, Payne CM, Tome ME, Briehl MM, Vasquez MA, Waltmire CN, Coon A, Dorr RT. Dvorakova K, et al. Among authors: tome me. Mol Cancer Ther. 2002 Jan;1(3):185-95. Mol Cancer Ther. 2002. PMID: 12467213

9

Role of antioxidant genes for the activity of artesunate against tumor cells.

Efferth T, Briehl MM, Tome ME. Efferth T, et al. Among authors: tome me. Int J Oncol. 2003 Oct;23(4):1231-5. Int J Oncol. 2003. PMID: 12964009

10

Overexpression of catalase or Bcl-2 delays or prevents alterations in phospholipid metabolism during glucocorticoid-induced apoptosis in WEHI7.2 cells.

Tome ME, Lutz NW, Briehl MM. Tome ME, et al. Biochim Biophys Acta. 2003 Oct 21;1642(3):149-62. doi: 10.1016/j.bbamcr.2003.08.002. Biochim Biophys Acta. 2003. PMID: 14572898 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page